Is there a synergic eVect of propafenone associated with atrial overdrive pacing for atrial arrhythmia prevention? A randomised crossover study
نویسندگان
چکیده
Objective—To assess the eVect of adding propafenone to atrial overdrive for the prevention of atrial arrhythmia episodes in patients with DDD pacemakers. Design—22 patients (8 female, 14 male, mean (SD) age 67 (9) years, range 48 to 77) with DDD pacemakers and frequent paroxysmal atrial arrhythmia episodes were evaluated in a randomised crossover study. Setting—University hospital. Methods—Atrial overdrive was defined as a paced rate of 10 paced beats/min above the mean ventricular rate stored for the last 24 hours in the pacemaker memory function. The protocol consisted of two phases of one month each. The first phase consisted of atrial overdrive alone, while in the second phase, propafenone (600 mg/day) was added to atrial overdrive (atrial overdrive + propafenone). All 22 patients underwent the two phases in random order. Results—Mean ventricular rate was 72 (8) beats/min with atrial overdrive v 73 (6) with atrial overdrive + propafenone (NS). With atrial overdrive, 14 patients (64.6%) had no recorded atrial arrhythmia v 15 (68.2%) with atrial overdrive + propafenone (NS). There was no statistical diVerence between the atrial overdrive and atrial overdrive + propafenone phases with regard to the number of atrial arrhythmia episodes (14 (27) v 13 (28)), their total duration (30 (78) v 29 (63) h), and their maximum duration (41 (72) v 31 (58) min). However, in the brady-tachy subgroup with persistent atrial arrhythmias, atrial overdrive + propafenone produced a shorter mean cumulative duration of atrial arrhythmia than atrial overdrive (104 (115) v 178 (149) h, p = 0.04), with a significant decrease in the number of atrial arrhythmia episodes (134 (98) v 102 (83), p = 0.05). The proportion of asymptomatic atrial arrhythmia episodes increased only in the AV block group during atrial overdrive + propafenone (p = 0.03). Three patients had atrial arrhythmias during atrial overdrive + propafenone but not with atrial overdrive alone. Conclusions—In DDD paced patients, the overall eVect of propafenone during atrial overdrive is variable. Propafenone may increase the proportion of asymptomatic atrial arrhythmia episodes. A proarrhythmic eVect of propafenone was documented (aggravation of atrial arrhythmias). These results need to be confirmed by further larger randomised studies. (Heart 2000;83:172–178)
منابع مشابه
Is there a synergic effect of propafenone associated with atrial overdrive pacing for atrial arrhythmia prevention? A randomised crossover study.
OBJECTIVE To assess the effect of adding propafenone to atrial overdrive for the prevention of atrial arrhythmia episodes in patients with DDD pacemakers. DESIGN 22 patients (8 female, 14 male, mean (SD) age 67 (9) years, range 48 to 77) with DDD pacemakers and frequent paroxysmal atrial arrhythmia episodes were evaluated in a randomised crossover study. SETTING University hospital. METHO...
متن کاملTemporary atrial epicardial pacing as prophylaxis against atrial fibrillation after heart surgery: a meta-analysis.
INTRODUCTION Recent studies have reported the use of temporary epicardial atrial pacing as prophylaxis for postoperative atrial fibrillation (AF). The aim of this study was to assess the effect of pacing therapies for prevention of postoperative AF using meta-analysis. METHODS AND RESULTS Using a computerized MEDLINE search, eight pacing prophylaxis trials with 776 patients were included in t...
متن کاملEfficacy of the DDD+ Overdrive Algorithm for the Suppression of Atrial Tachyarrhythmias
Atrial fibrillation (AF) persists as the most challenging arrhythmia in clinical practice, and it currently affects an estimated 400 million people worldwide. We view AF as the most common sustained supraventricular tachyarrhythmia, for it is associated with extensive morbidity and mortality [1]. According to some studies, AF is responsible for numerous hospitalizations, which result in signifi...
متن کاملNo incremental benefit of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation.
OBJECTIVE To evaluate the incremental antifibrillatory effect of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation paced for arrhythmia prevention alone. METHODS In 20 of these patients (mean (SD) age 64 (8) years; 14 female, six male), a single blinded randomised crossover study was performed to investigate the increment...
متن کاملSuppression of spontaneous ca elevations prevents atrial fibrillation in calsequestrin 2-null hearts.
BACKGROUND Atrial fibrillation (AF) risk has been associated with leaky ryanodine receptor 2 (RyR2) Ca release channels. Patients with mutations in RyR2 or in the sarcoplasmic reticulum Ca-binding protein calsequestrin 2 (Casq2) display an increased risk for AF. Here, we examine the underlying mechanisms of AF associated with loss of Casq2 and test mechanism-based drug therapy. METHODS AND RE...
متن کامل